Stem cell agency spinal cord injury clinical trial passes safety hurdles – Science Daily
|
Stem cell agency spinal cord injury clinical trial passes safety hurdles
Science Daily Asterias Biotherapeutics announced that its Data Monitoring Committee (DMC) has reviewed the safety data from the first two groups of patients treated and found no problems or adverse side effects. One group of three patients was given 2 million cells. |
